Li‐Kang Ho

832 citations
29 papers · 707 indexed · h-index 16
Topics
Bioactive Compounds and Antitumor Agents (6 papers)Phytochemistry and Biological Activities (6 papers)Natural product bioactivities and synthesis (5 papers)

In The Last Decade

Li‐Kang Ho

27 papers receiving 665 citations

Peers

Li‐Kang Ho
Comparison fields: 5 of 83
  • Molecular Biology 263
  • Organic Chemistry 130
  • Plant Science 129
  • Pharmacology 126
  • Toxicology 115
Replace Suvitha Syam with:
Suvitha Syam Malaysia
Hyun‐Ah Jung South Korea
Junting Fan China
Li‐Ming Yang Kuo Taiwan
Mi Hee Woo South Korea
Kanaya Lal Dhar India
Lean Teik Ng Taiwan
Yu‐Yi Chan Taiwan
Youn Chul Kim South Korea
Li‐Kang Ho relative to Suvitha Syam Malaysia Suvitha Syam's profile →
Citations per field
00.5×1.5×
Suvitha Syam · 1×
Citations per year

Countries citing papers authored by Li‐Kang Ho

Since Specialization
Citations

This map shows the geographic impact of Li‐Kang Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Kang Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Kang Ho more than expected).

Fields of papers citing papers by Li‐Kang Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Kang Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Kang Ho. The network helps show where Li‐Kang Ho may publish in the future.

Co-authorship network of co-authors of Li‐Kang Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Kang Ho. A scholar is included among the top collaborators of Li‐Kang Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Kang Ho. Li‐Kang Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 80
4 32
5 3
6 79
7 11
8 36
9 39
10 20
11 21
12 36
13 29
14 35
15 19
16 90
17 16
18 19
19
Highly Oxygenated Triterpeneoids from Pittosporum Tobira Ait.
1
20 5

About Li‐Kang Ho

Li‐Kang Ho is a scholar working on Toxicology, Complementary and alternative medicine and Pharmacology, having authored 29 papers that have together received 707 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (6 papers), Phytochemistry and Biological Activities (6 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Toxicology (115 citations), Complementary and alternative medicine (114 citations) and Pharmacology (97 citations). Li‐Kang Ho has collaborated with scholars based in Taiwan, Czechia and United States. Frequent co-authors include Yuan‐Shiun Chang, Ming‐Jaw Don, Ming-Jaw Don, Jau‐Ming Chen, Sheau-Farn Yeh, Chieh-Fu Chen, Yat‐Pang Chau, Yuh‐Chiang Shen, Tung‐Hu Tsai and Jer‐Huei Lin. Their work appears in journals such as Journal of Chromatography A, British Journal of Pharmacology and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026